Persistent behavioral impairment caused by embryonic methylphenidate exposure in zebrafish.

Area of Science:

• Neuroscience
• Developmental Toxicology
• Pharmacology

Background:

• Increasing use of methylphenidate for adult ADHD raises concerns about prenatal exposure risks.
• Previous studies linked developmental chlorpyrifos exposure to neurobehavioral deficits via dopamine system disruption.
• Methylphenidate, a dopamine agonist, may similarly impact neurobehavior after developmental exposure.

Purpose of the Study:

• To investigate the long-term neurobehavioral effects of developmental methylphenidate exposure in zebrafish.
• To determine if early methylphenidate exposure causes persistent behavioral impairments similar to other developmental toxicants.

Main Methods:

• Zebrafish embryos were exposed to methylphenidate (12.5-50 mg/l) from 0-5 days post-fertilization.
• Neurotransmitter levels (dopamine, norepinephrine, serotonin) were measured on days 6 and 30.
• Adult zebrafish were assessed for long-term behavioral changes using novel tank diving and three-chamber spatial learning tasks.

Main Results:

• A significant increase in dopamine, norepinephrine, and serotonin was observed on day 6 but not day 30 post-fertilization following 50 mg/l methylphenidate exposure.
• Developmental exposure to 50 mg/l methylphenidate significantly reduced the predatory avoidance diving response in adult zebrafish.
• Impaired choice accuracy in the spatial learning task was observed in adult zebrafish exposed to 50 mg/l methylphenidate during development.

Conclusions:

• Early developmental exposure to methylphenidate in zebrafish results in persistent, long-term neurobehavioral deficits.
• These findings demonstrate methylphenidate's potential as a neurobehavioral teratogen, impacting plasticity.
• Zebrafish serve as a valuable model for elucidating the molecular and cellular mechanisms underlying these functional deficits.